Log in to save to my catalogue

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin th...

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1654693080

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C

About this item

Full title

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C

Publisher

Tokyo: Springer Japan

Journal title

Journal of gastroenterology, 2014-12, Vol.49 (12), p.1548-1556

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
Older patients with chronic hepatitis C have a lower virological response to interferon (IFN) treatment compared to younger patients. The efficacy of telaprevir (TVR) and PEG-IFN plus ribavirin combination therapy and the predictive value of recently identified IFN lambda (IFNL) 4 polymorphisms on the outcome of therapy for older pati...

Alternative Titles

Full title

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1654693080

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1654693080

Other Identifiers

ISSN

0944-1174

E-ISSN

1435-5922

DOI

10.1007/s00535-013-0924-9

How to access this item